CIK 0000914475 · Large accelerated filer
NEUROCRINE BIOSCIENCES INC
Sign in to watch- Ticker
- NBIX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330525145
- Phone
- (858) 617-7600
- Business address
- 6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,162,347
- in 4 filings, $3.2M under 10b5-1 plans
Net −$3,162,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-08 | Lippoldt Darin Chief Legal Officer | Option exercise · Restricted Stock Unit 10b5-1 | −1,727 | 0 | ||
| 2025-02-08 | Gano Kyle Chief Executive Officer | Option exercise 10b5-1 | +1,860 | 138,638 | ||
| 2025-02-08 | Gano Kyle Chief Executive Officer | Option exercise · Restricted Stock Unit 10b5-1 | −1,860 | 0 | ||
| 2025-02-08 | Boyer David W. Chief Corp. Affairs Officer | Option exercise 10b5-1 | +1,329 | 2,698 | ||
| 2025-02-08 | Boyer David W. Chief Corp. Affairs Officer | Option exercise · Restricted Stock Unit 10b5-1 | −1,329 | 0 | ||
| 2025-02-08 | BENEVICH ERIC Chief Commercial Officer | Option exercise 10b5-1 | +1,860 | 43,779 | ||
| 2025-02-08 | BENEVICH ERIC Chief Commercial Officer | Option exercise · Restricted Stock Unit 10b5-1 | −1,860 | 0 | ||
| 2025-02-08 | ABERNETHY MATT Chief Financial Officer | Option exercise 10b5-1 | +1,860 | 34,541 | ||
| 2025-02-08 | ABERNETHY MATT Chief Financial Officer | Option exercise · Restricted Stock Unit 10b5-1 | −1,860 | 0 | ||
| 2025-02-03 | Delaet Ingrid Chief Regulatory Officer | Option exercise 10b5-1 | +1,179 | 4,065 | ||
| 2025-02-03 | Delaet Ingrid Chief Regulatory Officer | Sale 10b5-1 | −623 | $149.29 | $93K | 3,442 |
| 2025-02-03 | Delaet Ingrid Chief Regulatory Officer | Option exercise · Restricted Stock Unit 10b5-1 | −1,179 | 0 | ||
| 2025-01-31 | Cooke Julie Chief Human Resources Officer | Option exercise 10b5-1 | +1,740 | 19,942 | ||
| 2025-01-31 | Cooke Julie Chief Human Resources Officer | Sale 10b5-1 | −916 | $152.89 | $140K | 19,026 |
| 2025-01-31 | Cooke Julie Chief Human Resources Officer | Sale 10b5-1 | −824 | $152.89 | $126K | 18,202 |
| 2025-01-31 | Cooke Julie Chief Human Resources Officer | Option exercise · Restricted Stock Unit 10b5-1 | −1,740 | 1,741 | ||
| 2025-01-31 | GORMAN KEVIN CHARLES Director | Option exercise 10b5-1 | +5,141 | 519,737 | ||
| 2025-01-31 | GORMAN KEVIN CHARLES Director | Sale 10b5-1 | −2,707 | $152.92 | $414K | 517,030 |
| 2025-01-31 | GORMAN KEVIN CHARLES Director | Option exercise · Restricted Stock Unit 10b5-1 | −5,141 | 5,142 | ||
| 2025-01-31 | ROBERTS EIRY Chief Medical Officer | Option exercise 10b5-1 | +2,769 | 33,830 |
Page 25 of 49 · 963 trades